$2.80
0.13.70%
Pre-Market: Jan 17, 6:53 PM EDT
Comments
Loading...
VYNE Therapeutics (NASDAQ:VYNE) Stock, Earnings Estimates, EPS, And Revenue
VYNE Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS Estimate
$-0.310
Quarterly Revenue Estimate
$180.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$493.00K
Analyze the earnings history of VYNE Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
VYNE Therapeutics (VYNE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.29 | $-0.23 | -26.1 % |
| Q2 | 2024-08-14 | $-0.22 | $-0.19 | -15.8 % |
| Q1 | 2024-05-09 | $-0.15 | $-0.24 | 37.5 % |
| Q4 | 2024-02-29 | $-0.18 | $-0.50 | 64.0 % |
VYNE Therapeutics (VYNE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $121.00K | $110.00K | 10.0 % |
| Q2 | 2024-08-14 | $198.00K | $110.00K | 80.0 % |
| Q1 | 2024-05-09 | $98.00K | $100.00K | -2.00 % |
| Q4 | 2024-02-29 | $76.00K | $150.00K | -49.3 % |
FAQ
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics (VYNE) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for VYNE Therapeutics (NASDAQ:VYNE)?
The Actual EPS was $-0.29, which missed the estimate of $-0.23.
What were VYNE Therapeutics’s (NASDAQ:VYNE) revenues?
The Actual Revenue was $121K, which beat the estimate of $110K.
Browse earnings estimates, EPS, and revenue on all stocks.